This company recently went public with an IPO on Wednesday, July 2nd 2025. They issued 5,300,000 shares at $5.00 - $5.50 per share. We will continue to update data for CV as it becomes available. CapsoVision (CV) Competitors $4.37 -0.20 (-4.38%) As of 07/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock CV vs. DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, CTCXW, GMVDW, HSCSW, BEATW, and LUCYWShould you be buying CapsoVision stock or one of its competitors? The main competitors of CapsoVision include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Carmell (CTCXW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry. CapsoVision vs. Its Competitors Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care Carmell G Medical Innovations Heart Test Laboratories HeartBeam Innovative Eyewear CapsoVision (NASDAQ:CV) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends. Does the media favor CV or DRTSW? In the previous week, CapsoVision had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 2 mentions for CapsoVision and 1 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.89 beat CapsoVision's score of -0.50 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment CapsoVision Negative Alpha Tau Medical Very Positive Is CV or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets CapsoVisionN/A N/A N/A Alpha Tau Medical N/A N/A N/A Which has higher valuation and earnings, CV or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCapsoVisionN/AN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A SummaryCapsoVision and Alpha Tau Medical tied by winning 1 of the 2 factors compared between the two stocks. Get CapsoVision News Delivered to You Automatically Sign up to receive the latest news and ratings for CV and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CV vs. The Competition Export to ExcelMetricCapsoVisionSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$202.51M$56.86M$2.18B$9.14BDividend YieldN/AN/A2.64%4.00%P/E RatioN/AN/A22.2719.45Price / SalesN/A27.6697.1079.78Price / CashN/A1.4013.1527.47Price / BookN/A0.0674.955.58Net IncomeN/A-$82.29M-$134.41M$252.81M7 Day PerformanceN/A11.06%0.58%2.11%1 Month PerformanceN/A35.81%2.88%11.87%1 Year PerformanceN/A592.31%21.25%16.61% CapsoVision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVCapsoVisionN/A$4.37-4.4%N/AN/A$202.51MN/A0.0090News CoverageAnalyst UpgradeGap DownDRTSWAlpha Tau MedicalN/A$0.26-4.1%N/A+24.1%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.06flatN/A+4.3%$0.00N/A0.002ATAKWAurora Technology AcquisitionN/A$0.02-17.5%N/A-65.4%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$15.00flatN/A-78.6%$0.00N/A0.002Positive NewsBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011CTCXWCarmellN/A$0.03+6.8%N/AN/A$0.00$32.84K0.0014Gap UpGMVDWG Medical InnovationsN/AN/AN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.11+45.5%N/A+138.0%$0.00N/A0.0010Positive NewsGap UpBEATWHeartBeamN/A$0.26+2.8%N/A-62.2%$0.00N/A0.005Positive NewsLUCYWInnovative EyewearN/A$0.08-0.6%N/A-0.1%$0.00$1.71M0.009Positive NewsGap Down Related Companies and Tools Related Companies DRTSW Alternatives ANZUW Alternatives ATAKW Alternatives BBLGW Alternatives BRSHW Alternatives CTCXW Alternatives GMVDW Alternatives HSCSW Alternatives BEATW Alternatives LUCYW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CV) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CapsoVision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CapsoVision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CV Stock Alerts